GHK-Cu (copper tripeptide): chemistry, research and regulation

Abstract hexagonal molecular lattice in blue tones

Prepared by: Research Desk. Sources are linked for verification.

Published 19 October 2026

At a glance

Type: tripeptide (glycyl-L-histidyl-L-lysine, GHK) bound to a copper(II) ion
Origin: first described in human plasma in the early 1970s
Research stage: cell, animal and cosmetic-formulation research; limited controlled human data outside cosmetics
Regulatory status: used as a cosmetic ingredient; not an approved medicine

What GHK-Cu is

GHK is a tripeptide made of glycine, histidine and lysine. It binds copper(II) ions with high affinity, and the copper complex is known as GHK-Cu. In cosmetic ingredient lists it often appears as copper tripeptide-1. GHK occurs naturally in human plasma, saliva and urine, and several studies report that plasma levels are lower in older people than in younger people.

Research history

The tripeptide was first reported by Loren Pickart and Martin Thaler in 1973. In a paper in Nature New Biology, Pickart and Thaler described a factor in human serum that prolonged the survival of normal liver cells in culture and stimulated growth of liver tumour cells. That factor was later identified as GHK, and its copper-binding properties became a central part of the research story.

Over the following decades, research moved to connective tissue and skin. Much of the later literature has been summarised in reviews by Pickart and colleagues, including Pickart et al. (2012), Pickart et al. (2015) and Pickart and Margolina (2018).

Mechanisms studied in preclinical work

Extracellular matrix. Cell studies describe GHK stimulating both the synthesis and the breakdown of collagen and glycosaminoglycans, and modulating metalloproteinases and their inhibitors. This dual effect is often described as matrix remodelling.
Copper transport. Because GHK binds copper tightly, researchers have proposed that it can deliver copper to cells and influence copper-dependent enzymes.
Gene expression. Analyses of public gene-expression datasets, discussed in the 2018 review, suggest that GHK is associated with changes in the expression of a large number of human genes. These are computational associations from cell data, and their biological meaning is still being studied.
Wound models. Animal studies in rats, mice and pigs report effects on wound healing in experimental settings.

As with other peptides on this site, cell and animal results do not establish effects in people. Gene-expression associations in particular are hypothesis-generating rather than evidence of an outcome.

The published research landscape

GHK-Cu research falls into three broad groups:

Basic biology. Studies of the peptide's copper-binding chemistry, its presence in body fluids and its effects on cultured cells.
Animal models. Mostly experimental wound models.
Cosmetic formulation research. Studies of creams and serums containing copper peptides, often small and often funded by ingredient makers. Many cosmetic studies lack independent replication.

The authors of the main reviews are also the researchers who discovered and developed the compound, a point worth keeping in mind when weighing the literature. Independent systematic reviews of GHK-Cu are scarce.

Regulatory status

Cosmetics. Copper tripeptide-1 is used as an ingredient in cosmetic products sold in the US and EU. Cosmetic products cannot legally be marketed with drug claims.
United States, drugs. GHK-Cu is not an FDA-approved drug. FDA's page on bulk drug substances that may present significant safety risks lists GHK-Cu for injectable routes among substances whose category 2 nominations were withdrawn, citing possible immunogenicity due to aggregation and peptide-related impurities, and limited human data.
Sport. GHK-Cu is not named on WADA's Prohibited List as of 2026.

Open research questions

Copper or peptide? It is not always clear whether effects reported for GHK-Cu come from the peptide, from the copper it carries, or from the complex as a whole. Studies that compare GHK, GHK-Cu and copper salts side by side help separate these.
Stability in formulations. The copper complex can change with pH and in the presence of other ingredients, which matters for the reproducibility of laboratory and formulation work.
Independent replication. Larger, independently funded studies would show which of the reported cell and animal findings hold up.
Endogenous levels. The reported age-related fall in plasma GHK comes from a limited number of measurements, and modern assays could confirm or refine it.

Limitations of the evidence

Much of the literature comes from a small number of authors closely linked to the compound's discovery.
Cosmetic studies are often small, short and sponsor-funded.
Gene-expression findings are computational associations, not demonstrations of outcomes.

Where researchers source it

Purita is a store that lists GHK-Cu for laboratory research use only. Its product page carries the label "For Research Use Only. Not for human or animal administration."

Purita product page

Affiliate disclosure: this is a paid link. PeptideDiscoveryAI earns a commission if a purchase is made through it, at no extra cost to the buyer. A listing is not an endorsement or a statement about product quality. See the affiliate disclosure.